about the author

Julian Roberts-Grmela is a senior news editor for The Spectrum and an English and philosophy major. His favorite book is “White Teeth” by Zadie Smith and he hopes that one day his writing will be as good as hers. 


‘No justice, no peace’
Omran Albarazanchi wishes he had been “more vocal” when he heard instances of “pure racism” during high school.  
Goodbye UB
Last semester, my intramural soccer team lost in the semi-finals of the UB playoffs. It was a bummer for a team that still never won a championship. We’d come so close so many times over the last seven semesters.  “But at least we had one more opportunity,” we thought. “We still had the spring.” Turns out we didn’t. 
Incoming students worried about college experience
Tasfiah Khan always expected her freshman year of college would mean she could “become more independent.” She envisioned meeting new friends, creating her own schedule and settling into a new environment.  But Khan, a senior at Manhattan/Hunter Science High School who plans to enroll at UB in the fall, thinks her vision may be “crushed” by the coronavirus. She’s worried UB will extend its “distance-learning” model into the fall semester. UB already decided the summer term will operate entirely remotely.
Students share distance-learning challenges, UB hopes survey can address concerns
Jannat Inqiyad said that in order to complete the online work for her classes, she needs to leave her home since she doesn’t have internet access.  Inqiyad, a sophomore health and human services major, said her family had to “sacrifice” internet connection to afford essentials after the family lost its main source of income due to COVID-19.  Now, she needs to go to public libraries to complete her remote coursework and said she doesn’t feel safe leaving her house because she has family members and friends who are hospitalized with COVID-19. 
The memory of a mother: Student loses ‘best friend’ to COVID-19
Minnoli Aya never got to say goodbye to her mother, Madhvi.  Madhvi, the breadwinner of the family and “the person [Aya] would turn to when the world got ugly,” died alone in the hospital from COVID-19. She was 61.
Former acting UB president remembered as leader and scholar
Peter Regan, former acting UB president, executive vice president and professor, died at 95 on April 5.  Fifty years ago, Regan took over as acting president for one year from 1969-70, while President Martin Meyerson took a leave-of-absence, and later left UB.
Prorated refunds for student fees will be applied to student accounts ‘prior to the end of the semester’
UB has not yet provided a specific date that fee refunds will be applied to student accounts, but a university spokesperson said students will see prorated refunds “prior to the end of the semester.” The prorated fee refunds –– the percentage of money that will be refunded from the total fee –– will be “calculated on an individual basis” and “based on actual services provided,” according to UB spokesperson Kate McKenna.
Financial analyst denies ‘preconceived agenda’ in UB analysis
Howard Bunsis –– the Eastern Michigan University accounting professor who reported UB spends more on administration than any of its “peers” –– denies UB’s statement that his independent financial analysis had a “preconceived agenda.”  Bunsis’ report, which he released in February, called UB financial reporting “less transparent” than any of the over 100 universities he examined over the last 15 years. UB’s response urged readers to be “very skeptical of its findings” and said Bunsis had a “preconceived agenda” because he was hired. UB said the “report contains several flaws, inaccuracies and inconsistencies that misrepresent and misinterpret UB’s budget and budgeting process.” But Bunsis, in an April 3 email, said his report was based on “facts.”
UB contributes to local pandemic preparations
The Food and Drug Administration gave UB and Roswell Park Comprehensive Cancer Center permission Wednesday to begin a “collaborative clinical study” using an experimental drug, sarilumab, to try to treat some COVID-19 effects. Igor Puzanov, the trial’s co-principal investigator, hopes the drug, which reduces inflammation, may alleviate some of COVID-19’s worst symptoms like lung injury.